A clinical-stage pharmaceutical company developing innovative and groundbreaking therapeutics for autoimmune, inflammatory, and other debilitating diseases.
Today we officially rebranded Brickell Biotech, Inc. to Fresh Tracks Therapeutics, Inc. and established a Scientific Advisory Board. This #rebrand and #SAB highlight our commitment to developing novel therapies for #autoimmune and #inflammatory diseases. https://t.co/JFQImV2gfA